Targeted thorium-227 conjugates as treatment options in oncology

por Karlsson, Jenny, Schatz, Christoph A., Wengner, Antje M., Hammer, Stefanie, Scholz, Arne, Cuthbertson, Alan, Wagner, Volker, Hennekes, Hartwig, Jardine, Vicki, Hagemann, Urs B.
Publicado 2023

Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy

por Hagemann, Urs B., Wickstroem, Katrine, Hammer, Stefanie, Bjerke, Roger M., Zitzmann-Kolbe, Sabine, Ryan, Olav B., Karlsson, Jenny, Scholz, Arne, Hennekes, Hartwig, Mumberg, Dominik, Cuthbertson, Alan S.
Publicado 2020

Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models

por Hammer, Stefanie, Schlicker, Andreas, Zitzmann-Kolbe, Sabine, Baumgart, Simon, Hagemann, Urs B., Scholz, Arne, Haendler, Bernard, Lejeune, Pascale, Karlsson, Jenny, Ellingsen, Christine, Hennekes, Hartwig, Nielsen, Carsten H., Juul, Mark U., Mumberg, Dominik, Schatz, Christoph A.
Publicado 2021

Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy

por Lejeune, Pascale, Cruciani, Véronique, Berg-Larsen, Axel, Schlicker, Andreas, Mobergslien, Anne, Bartnitzky, Lisa, Berndt, Sandra, Zitzmann-Kolbe, Sabine, Kamfenkel, Claudia, Stargard, Stefan, Hammer, Stefanie, Jørgensen, Jennifer S, Jackerott, Malene, Nielsen, Carsten H, Schatz, Christoph A, Hennekes, Hartwig, Karlsson, Jenny, Cuthbertson, Alan S, Mumberg, Dominik, Hagemann, Urs B
Publicado 2021